Puri N - Search Results

1

Oligonucleotides Targeting Telomeres and Telomerase in Cancer.

Schrank Z, Khan N, Osude C, Singh S, Miller RJ, Merrick C, Mabel A, Kuckovic A, Puri N. Schrank Z, et al. Among authors: puri n. Molecules. 2018 Sep 5;23(9):2267. doi: 10.3390/molecules23092267. Molecules. 2018. PMID: 30189661 Free PMC article. Review.

2

Novel anticancer therapeutics targeting telomerase.

Ruden M, Puri N. Ruden M, et al. Among authors: puri n. Cancer Treat Rev. 2013 Aug;39(5):444-56. doi: 10.1016/j.ctrv.2012.06.007. Epub 2012 Jul 26. Cancer Treat Rev. 2013. PMID: 22841437 Review.

3

Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma.

Pitman RT, Wojdyla L, Puri N. Pitman RT, et al. Among authors: puri n. Oncotarget. 2013 May;4(5):761-71. doi: 10.18632/oncotarget.1047. Oncotarget. 2013. PMID: 23800953 Free PMC article.

4

Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

Puri N, Pitman RT, Mulnix RE, Erickson T, Iness AN, Vitali C, Zhao Y, Salgia R. Puri N, et al. Cancer Lett. 2014 Feb 1;343(1):14-23. doi: 10.1016/j.canlet.2013.09.010. Epub 2013 Sep 14. Cancer Lett. 2014. PMID: 24041868 Free PMC article.

5

Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.

Crees Z, Girard J, Rios Z, Botting GM, Harrington K, Shearrow C, Wojdyla L, Stone AL, Uppada SB, Devito JT, Puri N. Crees Z, et al. Among authors: puri n. Curr Pharm Des. 2014;20(41):6422-37. doi: 10.2174/1381612820666140630100702. Curr Pharm Des. 2014. PMID: 24975605 Review.

6

Current Molecularly Targeting Therapies in NSCLC and Melanoma.

Rajanna S, Rastogi I, Wojdyla L, Furo H, Kulesza A, Lin L, Sheu B, Frakes M, Ivanovich M, Puri N. Rajanna S, et al. Among authors: puri n. Anticancer Agents Med Chem. 2015;15(7):856-68. doi: 10.2174/1871520615666150202100130. Anticancer Agents Med Chem. 2015. PMID: 25642982 Review.

7

Treating Cancer by Targeting Telomeres and Telomerase.

Ivancich M, Schrank Z, Wojdyla L, Leviskas B, Kuckovic A, Sanjali A, Puri N. Ivancich M, et al. Among authors: puri n. Antioxidants (Basel). 2017 Feb 19;6(1):15. doi: 10.3390/antiox6010015. Antioxidants (Basel). 2017. PMID: 28218725 Free PMC article. Review.

8

Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.

Chhabra G, Wojdyla L, Frakes M, Schrank Z, Leviskas B, Ivancich M, Vinay P, Ganapathy R, Ramirez BE, Puri N. Chhabra G, et al. Among authors: puri n. J Invest Dermatol. 2018 Apr;138(4):903-910. doi: 10.1016/j.jid.2017.11.021. Epub 2017 Dec 2. J Invest Dermatol. 2018. PMID: 29203363 Free article.

9

Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC.

Iderzorig T, Kellen J, Osude C, Singh S, Woodman JA, Garcia C, Puri N. Iderzorig T, et al. Among authors: puri n. Biochem Biophys Res Commun. 2018 Feb 5;496(2):770-777. doi: 10.1016/j.bbrc.2018.01.069. Epub 2018 Jan 11. Biochem Biophys Res Commun. 2018. PMID: 29337056 Free PMC article.

10

Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance.

Schrank Z, Chhabra G, Lin L, Iderzorig T, Osude C, Khan N, Kuckovic A, Singh S, Miller RJ, Puri N. Schrank Z, et al. Among authors: puri n. Cancers (Basel). 2018 Jul 4;10(7):224. doi: 10.3390/cancers10070224. Cancers (Basel). 2018. PMID: 29973561 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

375 results

Search Page